Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARTEOLOL vs CASIMERSEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARTEOLOL vs CASIMERSEN: Safety Overview

Metric CARTEOLOL CASIMERSEN
Total FAERS Reports 318 767
Deaths Reported 30 7
Death Rate 9.4% 0.9%
Hospitalizations 93 87
Average Patient Age 67.5 yrs 14.0 yrs
% Female Patients 56.6% 0.4%
FDA Approval Date Dec 28, 1988 Feb 25, 2021
Manufacturer Sandoz Inc Sarepta Therapeutics, Inc.
Route OPHTHALMIC N/A
Marketing Status Discontinued Prescription